Joan Carles

Joan Carles

UNVERIFIED PROFILE

Are you Joan Carles?   Register this Author

Register author
Joan Carles

Joan Carles

Publications by authors named "Joan Carles"

Are you Joan Carles?   Register this Author

72Publications

2910Reads

29Profile Views

Clinical outcome after progressing to frontline and second-line Anti-PD-1/PD-L1 in advanced urothelial cancer.

Authors:
Alfonso Gómez de Liaño Lista Nick van Dijk Guillermo de Velasco Oria de Rueda Andrea Necchi Pernelle Lavaud Rafael Morales-Barrera Teresa Alonso Gordoa Pablo Maroto Alain Ravaud Ignacio Durán Bernadett Szabados Daniel Castellano Patrizia Giannatempo Yohann Loriot Joan Carles Georgia Anguera Palacios Felix Lefort Daniele Raggi Marine Gross Goupil Thomas Powles Michiel S Van der Heijden

Eur Urol 2020 Feb 5;77(2):269-276. Epub 2019 Nov 5.

Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2019.10.004DOI Listing
February 2020

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.

Authors:
César Serrano Ana Vivancos Antonio López-Pousa Judit Matito Francesco M Mancuso Claudia Valverde Sergi Quiroga Stefania Landolfi Sandra Castro Cristina Dopazo Ana Sebio Anna C Virgili María M Menso Javier Martín-Broto Miriam Sansó Alfonso García-Valverde Jordi Rosell Jonathan A Fletcher Suzanne George Joan Carles Joaquín Arribas

BMC Cancer 2020 Feb 5;20(1):99. Epub 2020 Feb 5.

Preclinical Research Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s12885-020-6597-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003348PMC
February 2020

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.

Authors:
Ronald de Wit Johann de Bono Cora N Sternberg Karim Fizazi Bertrand Tombal Christian Wülfing Gero Kramer Jean-Christophe Eymard Aristotelis Bamias Joan Carles Roberto Iacovelli Bohuslav Melichar Ásgerður Sverrisdóttir Christine Theodore Susan Feyerabend Carole Helissey Ayse Ozatilgan Christine Geffriaud-Ricouard Daniel Castellano

N Engl J Med 2019 12 30;381(26):2506-2518. Epub 2019 Sep 30.

From the Erasmus Medical Center, Rotterdam, the Netherlands (R.W.); the Institute of Cancer Research and the Royal Marsden Hospital, London (J.B.); Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); Institut Gustave Roussy and University of Paris Sud, Villejuif (K.F.), Jean Godinot Institute and Reims Champagne-Ardenne University, Reims (J.-C.E.), Foch Hospital, Suresnes (C.T.), Hôpital d'Instruction des Armées Bégin, Saint Mandé (C.H.), and Sanofi, Europe Medical Oncology, Paris (C.G.-R.) - all in France; Institut de Recherche Clinique, Université Catholique de Louvain, Louvain, Belgium (B.T.); the Department of Urology, Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona, Hamburg (C.W.), and Studienpraxis Urologie, Nürtingen (S.F.) - both in Germany; the Medical University of Vienna, Vienna (G.K.); Alexandra Hospital, National and Kapodistrian University of Athens, Athens (A.B.); Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona (J.C.); Azienda Ospedaliera Universitaria Integrata, Verona, and Fondazione Policlinico Agostino Gemelli IRCCS, Rome - both in Italy (R.I.); Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic (B.M.); Landspitali University Hospital, Reykjavik, Iceland (Á.S.); Sanofi, Global Medical Oncology, Cambridge, MA (A.O.); and 12 de Octubre University Hospital, Madrid (D.C.).

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMoa1911206DOI Listing
December 2019

Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria.

Authors:
Ignacio Matos Juan Martin-Liberal Alonso García-Ruiz Cinta Hierro Maria Ochoa de Olza Cristina Viaplana Analia Azaro Maria Vieito Irene Braña Gemma Mur Javier Ros Jose Mateos Guillermo Villacampa Roger Berché Mafalda Oliveira Maria Alsina Elena Elez Ana Oaknin Eva Muñoz-Couselo Joan Carles Enriqueta Felip Jordi Rodón Josep Tabernero Rodrigo Dienstmann Raquel Perez-Lopez Elena Garralda

Clin Cancer Res 2019 Nov 22. Epub 2019 Nov 22.

Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-2226DOI Listing
November 2019

The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer.

Authors:
Mercedes Marín-Aguilera Òscar Reig Maria Milà-Guasch Albert Font Montserrat Domènech Alejo Rodríguez-Vida Joan Carles Cristina Suárez Aránzazu González Del Alba Natalia Jiménez Iván Victoria Núria Sala-González Maria José Ribal Sandra López Olatz Etxaniz Geòrgia Anguera Pablo Maroto Pedro Luis Fernández Aleix Prat Begoña Mellado

Int J Cancer 2019 10 23;145(7):1970-1981. Epub 2019 Mar 23.

Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/ijc.32238DOI Listing
October 2019

Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program.

Authors:
Fred Saad Silke Gillessen Daniel Heinrich Daniel Keizman Joe M O'Sullivan Sten Nilsson Kurt Miller Manfred Wirth John Reeves Monica Seger Joan Carles Axel Heidenreich

Clin Genitourin Cancer 2019 10 31;17(5):348-355.e5. Epub 2019 May 31.

Department of Urology, University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673193015
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2019.05.012DOI Listing
October 2019

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib.

Authors:
César Serrano Xavier García-Del-Muro Claudia Valverde Ana Sebio José Durán Aránzazu Manzano Isabel Pajares Nadia Hindi Stefania Landolfi Laura Jiménez Jordi Rubió-Casadevall Anna Estival Javier Lavernia María José Safont Carles Pericay Roberto Díaz-Beveridge Virginia Martínez-Marín David Vicente-Baz Ana Vivancos Javier Hernández-Losa Joaquín Arribas Joan Carles

Oncologist 2019 05 20;24(5):680-687. Epub 2018 Aug 20.

Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1634/theoncologist.2018-0032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516132PMC
May 2019

Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.

Authors:
James L Gulley Michael Borre Nicholas J Vogelzang Siobhan Ng Neeraj Agarwal Chris C Parker David W Pook Per Rathenborg Thomas W Flaig Joan Carles Fred Saad Neal D Shore Liddy Chen Christopher R Heery Winald R Gerritsen Frank Priou Niels C Langkilde Andrey Novikov Philip W Kantoff

J Clin Oncol 2019 May 28;37(13):1051-1061. Epub 2019 Feb 28.

18 Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

 Source
http://ascopubs.org/doi/10.1200/JCO.18.02031
Publisher Site
http://dx.doi.org/10.1200/JCO.18.02031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494360PMC
May 2019

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA).

Authors:
Joan Carles Angelika Pichler Hana Korunkova Antoaneta Tomova Marwan Ghosn Fadi El Karak Joseph Makdessi Irina Koroleva Gisoo Barnes Denise Bury Ayse Özatilgan Simon Hitier Jana Katolicka

BJU Int 2019 03 16;123(3):456-464. Epub 2018 Sep 16.

Department of Oncology, St. Ann's University Hospital, Brno, Czech Republic.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bju.14509DOI Listing
March 2019

Towards a New Classification for Metastatic Prostate Cancer.

Authors:
Joaquin Mateo Joan Carles

Eur Urol 2019 03 19;75(3):383-384. Epub 2018 Nov 19.

Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2018.10.058DOI Listing
March 2019

Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer.

Authors:
Alejandro Athie Sara Arce-Gallego Macarena Gonzalez Rafael Morales-Barrera Cristina Suarez Teresa Casals Galobart Gonzalo Hernandez Viedma Joan Carles Joaquin Mateo

Curr Oncol Rep 2019 Mar 27;21(5):42. Epub 2019 Mar 27.

Prostate Cancer Translational Research Group, Vall d'Hebron Institute of Oncology (VHIO), Cellex Center, Natzaret 115-117, 08035, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s11912-019-0790-6DOI Listing
March 2019

Nanoparticles as theranostic vehicles in prostate cancer.

Authors:
Rafael Morales-Barrera Cristina Suárez Joaquín Mateo Macarena González Joan Carles

Ann Transl Med 2019 Mar;7(Suppl 1):S29

Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.21037/atm.2019.01.77DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462597PMC
March 2019

Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group.

Authors:
Joe M O'Sullivan Joan Carles Richard Cathomas Alfonso Gomez-Iturriaga Daniel Heinrich Gero Kramer Piet Ost Inge van Oort Bertrand Tombal

Eur Urol Oncol 2019 Mar 25. Epub 2019 Mar 25.

Cliniques Universitaires Saint-Luc, Brussels, Belgium.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.euo.2019.02.007DOI Listing
March 2019

Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients.

Authors:
Joan Carles Enrique Gallardo Montserrat Doménech Albert Font Joaquim Bellmunt Mariona Figols Begoña Mellado María Isabel Sáez Cristina Suárez María José Méndez Pablo Maroto Raquel Luque Teresa de Portugal Ramón Aldabo Teresa Bonfill Rafael Morales-Barrera José García Sonia Maciá Xavier Maldonado Palmira Foro

Int J Radiat Oncol Biol Phys 2019 02 12;103(2):344-352. Epub 2018 Oct 12.

Radiation Oncology Department, Hospital del Mar, IMIM, Barcelona, Spain.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016183385
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2018.10.005DOI Listing
February 2019

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program.

Authors:
Axel Heidenreich Silke Gillessen Daniel Heinrich Daniel Keizman Joe M O'Sullivan Joan Carles Manfred Wirth Kurt Miller John Reeves Monica Seger Sten Nilsson Fred Saad

BMC Cancer 2019 Jan 7;19(1):12. Epub 2019 Jan 7.

Department of Urology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.

View Article

Download full-text PDF

 Source
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-
Publisher Site
http://dx.doi.org/10.1186/s12885-018-5203-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322274PMC
January 2019

Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer.

Authors:
Joan Carles Daniel Castellano María-José Méndez-Vidal Begoña Mellado María-Isabel Saez Aránzazu González Del Alba José-Luis Perez-Gracia José Jimenez Cristina Suárez Juan M Sepúlveda Ray Manneh Ignacio Porras Cristina López Rafael Morales-Barrera José-Ángel Arranz

Clin Genitourin Cancer 2018 12 21;16(6):e1133-e1139. Epub 2018 Jul 21.

Medical Oncology Department, Gregorio Marañón University Hospital, Madrid, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clgc.2018.07.013DOI Listing
December 2018

The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score.

Authors:
Kurt Miller Joan Carles Jürgen E Gschwend Hendrik Van Poppel Joris Diels Sabine D Brookman-May

Eur Urol 2018 07 20;74(1):17-23. Epub 2017 Sep 20.

Department of Urology, Ludwig-Maximilians University (LMU) Munich, Munich, Germany; Janssen Research & Development, Los Angeles, California, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2017.08.035DOI Listing
July 2018

Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.

Authors:
Francisco Martínez-Ricarte Regina Mayor Elena Martínez-Sáez Carlota Rubio-Pérez Estela Pineda Esteban Cordero Marta Cicuéndez Maria A Poca Nuria López-Bigas Santiago Ramon Y Cajal María Vieito Joan Carles Josep Tabernero Ana Vivancos Soledad Gallego Francesc Graus Juan Sahuquillo Joan Seoane

Clin Cancer Res 2018 06 3;24(12):2812-2819. Epub 2018 Apr 3.

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3800DOI Listing
June 2018

Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure: The UPWARD Study.

Authors:
Susan Slovin William Clark Joan Carles Andrew Krivoshik Jung Wook Park Fong Wang Daniel George

JAMA Oncol 2018 05;4(5):702-706

Divisions of Medical Oncology and Urology, Duke Cancer Institute, Durham, North Carolina.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1001/jamaoncol.2017.3361DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145657PMC
May 2018

Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy.

Authors:
Juan Morote Inma Comas Jacques Planas Xavier Maldonado Ana Celma José Placer Roser Ferrer Joan Carles Lucas Regis

Clin Genitourin Cancer 2018 04 2;16(2):e491-e496. Epub 2017 Dec 2.

Department of Urology, Vall d'Hebron Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clgc.2017.10.025DOI Listing
April 2018

Detection of circulating tumor DNA for advanced bladder cancer: where are we going?

Authors:
Rafael Morales-Barrera Macarena González Cristina Suárez Joan Carles

Transl Androl Urol 2018 Mar;7(Suppl 1):S101-S103

Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.21037/tau.2018.01.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881193PMC
March 2018

Radium-223 international early access program: results from the Spanish subset.

Authors:
Joan Carles Mª José Méndez Álvaro Pinto Mª Isabel Sáez José A Arranz Pablo Maroto Pilar López-Criado Begoña Mellado Jesús García Donas Susana Hernando Luís León Aránzazu González Del Alba Núria Laínez Emilio Esteban Gaspar Reynés José L Pérez-Gracia Josep R Germà Marta López-Brea Begoña Pérez-Valderrama Cristina Moretones Daniel Castellano

Future Oncol 2018 Jan 13;14(1):41-50. Epub 2017 Dec 13.

Department of Medical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2217/fon-2017-0297DOI Listing
January 2018

Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.

Authors:
Joshi J Alumkal Simon Chowdhury Yohann Loriot Cora N Sternberg Johann S de Bono Bertrand Tombal Joan Carles Thomas W Flaig Tanya B Dorff De Phung David Forer Sarah B Noonberg Hank Mansbach Tomasz M Beer Celestia S Higano

Clin Genitourin Cancer 2017 10 3;15(5):610-617.e3. Epub 2017 Mar 3.

Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clgc.2017.02.007DOI Listing
October 2017

Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m) and the Currently Approved Dose (25 mg/m) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA.

Authors:
Mario Eisenberger Anne-Claire Hardy-Bessard Choung Soo Kim Lajos Géczi Daniel Ford Loïc Mourey Joan Carles Phillip Parente Albert Font Gabriel Kacso Mustapha Chadjaa Wenping Zhang John Bernard Johann de Bono

J Clin Oncol 2017 Oct 15;35(28):3198-3206. Epub 2017 Aug 15.

Mario Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Anne-Claire Hardy-Bessard, Centre Armoricain d'Oncologie, Centre Armoricain de Radiothérapie, d'Imagerie Médicale et d'Oncologie-Hôpital Privé Des Côtes d'Armor, Plérin; Loïc Mourey, Institut Claudius Regaud, l'Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Mustapha Chadjaa, Sanofi, Vitry-sur-Seine, France; Choung Soo Kim, Asan Medical Center, Seoul, South Korea; Lajos Géczi, National Institute of Oncology, Budapest, Hungary; Daniel Ford, City Hospital, Cancer Centre at Queen Elizabeth Hospital, Birmingham; Johann de Bono, Prostate Cancer Targeted Therapy Team, Royal Marsden National Health Service Foundation Trust/The Institute of Cancer Research, Sutton, United Kingdom; Joan Carles, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Phillip Parente, Eastern Health Clinical School, Monash University, Box Hill Hospital, Melbourne, Victoria, Australia; Albert Font, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Gabriel Kacso, Iuliu Hatieganu Medical University, Amethyst Radiology Therapeutic Center, Cluj, Romania; Wenping Zhang, Sanofi, Bridgewater, NJ; and John Bernard, Sanofi, Cambridge, MA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2016.72.1076DOI Listing
October 2017

Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line Studies.

Authors:
Samer Salah Jae-Lyun Lee Antonio Rozzi Hiroshi Kitamura Kazumasa Matsumoto Daniel J Vis Sandy Srinivas Rafael Morales-Barrera Joan Carles Dalia Al-Rimawi Soonil Lee Ki Hong Kim Kouji Izumi Jeremy Lewin

Clin Genitourin Cancer 2017 08 22;15(4):e563-e571. Epub 2016 Dec 22.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Canada.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clgc.2016.12.014DOI Listing
August 2017

Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone.

Authors:
Charles J Ryan Thian Kheoh Jinhui Li Arturo Molina Peter De Porre Joan Carles Eleni Efstathiou Philip W Kantoff Peter F A Mulders Fred Saad Kim N Chi

Clin Genitourin Cancer 2017 Jul 25. Epub 2017 Jul 25.

BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clgc.2017.07.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785489PMC
July 2017

Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.

Authors:
César Serrano Suzanne George Claudia Valverde David Olivares Alfonso García-Valverde Cristina Suárez Rafael Morales-Barrera Joan Carles

Target Oncol 2017 06;12(3):277-288

Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, P. Vall d'Hebron 119, 08035, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s11523-017-0490-9DOI Listing
June 2017

Unveiling changes in the landscape of patient populations in cancer early drug development.

Authors:
Cinta Hierro Analía Azaro Guillem Argilés Elena Elez Patricia Gómez Joan Carles Jordi Rodon

Oncotarget 2017 Feb;8(8):14158-14172

Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.18632/oncotarget.13258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355170PMC
February 2017

Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.

Authors:
Lucas Regis Jacques Planas Joan Carles Xavier Maldonado Inma Comas Roser Ferrer Juan Morote

Prostate 2017 01 1;77(1):114-120. Epub 2016 Nov 1.

Department of Urology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1002/pros.23256
Publisher Site
http://dx.doi.org/10.1002/pros.23256DOI Listing
January 2017

Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.

Authors:
Rafael Morales-Barrera Cristina Suárez Ana Martínez de Castro Fabricio Racca Claudia Valverde Xavier Maldonado Juan Maria Bastaros Juan Morote Joan Carles

Cancer Treat Rev 2016 Nov 1;50:208-216. Epub 2016 Oct 1.

Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ctrv.2016.09.018DOI Listing
November 2016

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.

Authors:
Sebastian Moran Anna Martínez-Cardús Sergi Sayols Eva Musulén Carme Balañá Anna Estival-Gonzalez Cátia Moutinho Holger Heyn Angel Diaz-Lagares Manuel Castro de Moura Giulia M Stella Paolo M Comoglio Maria Ruiz-Miró Xavier Matias-Guiu Roberto Pazo-Cid Antonio Antón Rafael Lopez-Lopez Gemma Soler Federico Longo Isabel Guerra Sara Fernandez Yassen Assenov Christoph Plass Rafael Morales Joan Carles David Bowtell Linda Mileshkin Daniela Sia Richard Tothill Josep Tabernero Josep M Llovet Manel Esteller

Lancet Oncol 2016 Oct 27;17(10):1386-1395. Epub 2016 Aug 27.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain; School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(16)30297-2DOI Listing
October 2016

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.

Authors:
Fred Saad Joan Carles Silke Gillessen Axel Heidenreich Daniel Heinrich Jeremy Gratt Jérémy Lévy Kurt Miller Sten Nilsson Oana Petrenciuc Marcello Tucci Manfred Wirth Judith Federhofer Joe M O'Sullivan

Lancet Oncol 2016 Sep 26;17(9):1306-16. Epub 2016 Jul 26.

The Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland; Northern Ireland Cancer Centre, Belfast, Northern Ireland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(16)30173-5DOI Listing
September 2016

Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.

Authors:
Samer Salah Jae-Lyun Lee Antonio Rozzi Hiroshi Kitamura Kazumasa Matsumoto Sandy Srinivas Rafael Morales-Barrera Joan Carles Rami Al-Wardat Kamal Al-Rabi Mohammad Maakoseh

Clin Genitourin Cancer 2016 Jun 24;14(3):255-60. Epub 2015 Oct 24.

Medical Oncology Department, King Hussein Cancer Center, Al-Jubeiha, Amman, Jordan.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clgc.2015.10.006DOI Listing
June 2016

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients.

Authors:
Gabriela Jiménez-Valerio Mar Martínez-Lozano Nicklas Bassani August Vidal María Ochoa-de-Olza Cristina Suárez Xavier García-Del-Muro Joan Carles Francesc Viñals Mariona Graupera Stefano Indraccolo Oriol Casanovas

Cell Rep 2016 05 28;15(6):1134-43. Epub 2016 Apr 28.

Tumor Angiogenesis Group, ProCURE, Catalan Institute of Oncology - IDIBELL, 08908 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.celrep.2016.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870515PMC
May 2016

A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.

Authors:
Ricard Mesía Silvia Vázquez Juan J Grau Jose A García-Sáenz Alicia Lozano Carlos García Joan Carles Antonio Irigoyen Manel Mañós Beatriz García-Paredes Elvira del Barco Miren Taberna Yolanda Escobar Juan J Cruz

Int J Radiat Oncol Biol Phys 2016 Feb 22;94(2):289-96. Epub 2015 Oct 22.

Medical Oncology Department, Hospital Clínico de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2015.10.019DOI Listing
February 2016

RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.

Authors:
César Serrano Cleofé Romagosa Javier Hernández-Losa Sara Simonetti Claudia Valverde Teresa Moliné Rosa Somoza Manuel Pérez Roberto Vélez Ramona Vergés Rosa Domínguez Joan Carles Santiago Ramón Y Cajal

Cancer 2016 Jan 19;122(1):99-107. Epub 2015 Oct 19.

Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cncr.29733DOI Listing
January 2016

Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer.

Authors:
Miguel Ángel Climent Luis León-Mateos Aránzazu González Del Alba Begoña Pérez-Valderrama M José Méndez-Vidal Begoña Mellado José Ángel Arranz Alfredo Sánchez-Hernández Javier Cassinello David Olmos Joan Carles

Crit Rev Oncol Hematol 2015 Nov 8;96(2):308-18. Epub 2015 Jun 8.

Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.critrevonc.2015.05.019DOI Listing
November 2015

Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer.

Authors:
Matthew R Smith Dana E Rathkopf Peter F A Mulders Joan Carles Hendrik Van Poppel Jinhui Li Thian Kheoh Thomas W Griffin Arturo Molina Charles J Ryan

J Urol 2015 Nov 4;194(5):1277-84. Epub 2015 Jul 4.

Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.juro.2015.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129174PMC
November 2015

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.

Authors:
Leticia De Mattos-Arruda Regina Mayor Charlotte K Y Ng Britta Weigelt Francisco Martínez-Ricarte Davis Torrejon Mafalda Oliveira Alexandra Arias Carolina Raventos Jiabin Tang Elena Guerini-Rocco Elena Martínez-Sáez Sergio Lois Oscar Marín Xavier de la Cruz Salvatore Piscuoglio Russel Towers Ana Vivancos Vicente Peg Santiago Ramon y Cajal Joan Carles Jordi Rodon María González-Cao Josep Tabernero Enriqueta Felip Joan Sahuquillo Michael F Berger Javier Cortes Jorge S Reis-Filho Joan Seoane

Nat Commun 2015 11 10;6:8839. Epub 2015 Nov 10.

Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, P. Vall d'Hebron 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/ncomms9839DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426516PMC
November 2015

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.

Authors:
Charles J Ryan Matthew R Smith Karim Fizazi Fred Saad Peter F A Mulders Cora N Sternberg Kurt Miller Christopher J Logothetis Neal D Shore Eric J Small Joan Carles Thomas W Flaig Mary-Ellen Taplin Celestia S Higano Paul de Souza Johann S de Bono Thomas W Griffin Peter De Porre Margaret K Yu Youn C Park Jinhui Li Thian Kheoh Vahid Naini Arturo Molina Dana E Rathkopf

Lancet Oncol 2015 Feb 16;16(2):152-60. Epub 2015 Jan 16.

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(14)71205-7DOI Listing
February 2015

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

Authors:
Dana E Rathkopf Matthew R Smith Johann S de Bono Christopher J Logothetis Neal D Shore Paul de Souza Karim Fizazi Peter F A Mulders Paul Mainwaring John D Hainsworth Tomasz M Beer Scott North Yves Fradet Hendrik Van Poppel Joan Carles Thomas W Flaig Eleni Efstathiou Evan Y Yu Celestia S Higano Mary-Ellen Taplin Thomas W Griffin Mary B Todd Margaret K Yu Youn C Park Thian Kheoh Eric J Small Howard I Scher Arturo Molina Charles J Ryan Fred Saad

Eur Urol 2014 Nov 6;66(5):815-25. Epub 2014 Mar 6.

CRCHUM, University of Montréal, Montréal, Québec, Canada.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2014.02.056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418928PMC
November 2014

Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma.

Authors:
Celia Prior Jose Luis Perez-Gracia Jesus Garcia-Donas Cristina Rodriguez-Antona Elizabeth Guruceaga Emilio Esteban Cristina Suarez Daniel Castellano Aránzazu González del Alba Maria Dolores Lozano Joan Carles Miguel Angel Climent Jose Angel Arranz Enrique Gallardo Javier Puente Joaquim Bellmunt Alfonso Gurpide Jose Maria Lopez-Picazo Alvaro Gonzalez Hernandez Begoña Mellado Esther Martínez Fernando Moreno Albert Font Alfonso Calvo

PLoS One 2014 24;9(1):e86263. Epub 2014 Jan 24.

Oncology Division, CIMA, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

 Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086263PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901669PMC
October 2014

Phase I study of sunitinib in combination with gemcitabine and capecitabine for first-line treatment of metastatic or unresectable renal cell carcinoma.

Authors:
Joaquim Bellmunt Cristina Suarez Enrique Gallardo Jordi Rodon Francesc Pons Teresa Bonfill Marta Beltran Irene Moya Susana Galtes Joan Albanell Joan Carles

Oncologist 2014 Sep 20;19(9):917-8. Epub 2014 Aug 20.

Vall d'Hebron University Hospital, Universitat Autonoma of Barcelona, Barcelona, Spain;

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1634/theoncologist.2014-0072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153461PMC
September 2014

Enzalutamide in metastatic prostate cancer before chemotherapy.

Authors:
Tomasz M Beer Andrew J Armstrong Dana E Rathkopf Yohann Loriot Cora N Sternberg Celestia S Higano Peter Iversen Suman Bhattacharya Joan Carles Simon Chowdhury Ian D Davis Johann S de Bono Christopher P Evans Karim Fizazi Anthony M Joshua Choung-Soo Kim Go Kimura Paul Mainwaring Harry Mansbach Kurt Miller Sarah B Noonberg Frank Perabo De Phung Fred Saad Howard I Scher Mary-Ellen Taplin Peter M Venner Bertrand Tombal

N Engl J Med 2014 Jul 1;371(5):424-33. Epub 2014 Jun 1.

The authors' affiliations are listed in the Appendix.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMoa1405095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418931PMC
July 2014

Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen.

Authors:
Daniel E Castellano Joaquim Bellmunt José Pablo Maroto Albert Font-Pous Rafael Morales-Barrera Ismael Ghanem Cristina Suarez Cristina Martín Lorente Olatz Etxaniz Laia Capdevila Cinthya Coronado Vicente Alfaro Mariano Siguero Carlos Fernández-Teruel Joan Carles

Cancer Chemother Pharmacol 2014 Apr 26;73(4):857-67. Epub 2014 Feb 26.

Hospital Universitario Doce de Octubre, Avda. Córdoba s/n, 28041, Madrid, Spain,

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00280-014-2419-7DOI Listing
April 2014

Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study.

Authors:
Palmira Foro Manuel Algara Joan Lozano Nuria Rodriguez Xavier Sanz Erica Torres Joan Carles Anna Reig Ismael Membrive Jaume Quera Enric Fernandez-Velilla Oscar Pera Marti Lacruz Beatriz Bellosillo

Int J Radiat Oncol Biol Phys 2014 Apr;88(5):1057-63

Universitat Pompeu Fabra, Barcelona, Spain; Pathology Department, Parc de Salut Mar, Barcelona, Spain.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016140000
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2014.01.002DOI Listing
April 2014

Role of immunotherapy in castration-resistant prostate cancer (CRPC).

Authors:
Cristina Suárez Rafael Morales-Barrera Victor Ramos Isaac Núñez Claudia Valverde Jacques Planas Juan Morote Xavier Maldonado Joan Carles

BJU Int 2014 Mar 12;113(3):367-75. Epub 2013 Apr 12.

Genitourinary, Sarcoma, and Central Nervous System Tumor Program, Medical Oncology Department, Universitat Autònoma Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bju.12110DOI Listing
March 2014

Metabolic syndrome increases the risk of aggressive prostate cancer detection.

Authors:
Juan Morote Jordi Ropero Jacques Planas Juan M Bastarós Gueisy Delgado José Placer Anna Celma Inés M de Torres Joan Carles Jaume Reventós Andreas Doll

BJU Int 2013 Jun 9;111(7):1031-6. Epub 2012 Aug 9.

Department of Urology, Universitat Autónoma de Barcelona, Paseo Vall d'Hebron 119-129, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11406.xDOI Listing
June 2013

BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours.

Authors:
César Serrano Sara Simonetti Javier Hernández-Losa Claudia Valverde Cristina Carrato Silvia Bagué Ruth Orellana Rosa Somoza Teresa Moliné Joan Carles Pere Huguet Cleofé Romagosa Santiago Ramón y Cajal

Histopathology 2013 Feb 27;62(3):499-504. Epub 2012 Nov 27.

Department of Oncology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Passeig de la Vall d’Hebron 119–129, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/his.12021DOI Listing
February 2013

Abiraterone in metastatic prostate cancer without previous chemotherapy.

Authors:
Charles J Ryan Matthew R Smith Johann S de Bono Arturo Molina Christopher J Logothetis Paul de Souza Karim Fizazi Paul Mainwaring Josep M Piulats Siobhan Ng Joan Carles Peter F A Mulders Ethan Basch Eric J Small Fred Saad Dirk Schrijvers Hendrik Van Poppel Som D Mukherjee Henrik Suttmann Winald R Gerritsen Thomas W Flaig Daniel J George Evan Y Yu Eleni Efstathiou Allan Pantuck Eric Winquist Celestia S Higano Mary-Ellen Taplin Youn Park Thian Kheoh Thomas Griffin Howard I Scher Dana E Rathkopf

N Engl J Med 2013 Jan 10;368(2):138-48. Epub 2012 Dec 10.

Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMoa1209096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683570PMC
January 2013

Evaluation of patients with metastatic renal cell carcinoma after failure of first-line treatment.

Authors:
Joan Carles Isabel Chirivella Miguel Angel Climent Enrique Gallardo Arancha González del Alba José Pablo Maroto Begoña Mellado Francisco Xavier García del Muro

Cancer Metastasis Rev 2012 Sep;31 Suppl 1:S3-9

Medical Oncology Service, Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s10555-012-9353-0DOI Listing
September 2012

Recommendations for the optimal management of early and advanced urothelial carcinoma.

Authors:
Daniel Castellano Joan Carles Emilio Esteban José Manuel Trigo Miguel Ángel Climent José Pablo Maroto Xavier García del Muro Albert Font Luis Paz-Ares José Ángel Arranz Joaquim Bellmunt

Cancer Treat Rev 2012 Aug 23;38(5):431-41. Epub 2011 Nov 23.

Medical Oncology Department, Hospital Universitario 12 de Octubre, Avda. De Córdoba, S/N. 28041 Madrid, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ctrv.2011.10.004DOI Listing
August 2012

Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function.

Authors:
Rafael Morales-Barrera Joaquim Bellmunt Cristina Suárez Claudia Valverde Marta Guix Cesar Serrano Manuel Gallén Joan Carles

Eur J Cancer 2012 Aug 16;48(12):1816-21. Epub 2012 May 16.

Department of Medical Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

 Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491200322
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2012.04.002DOI Listing
August 2012

Emerging therapies for urothelial cancer.

Authors:
César Serrano Rafael Morales Cristina Suárez Isaac Núñez Claudia Valverde Jordi Rodón Jordi Humbert Olga Padrós Joan Carles

Cancer Treat Rev 2012 Jun 22;38(4):311-7. Epub 2011 Nov 22.

Genitourinary, Sarcoma and Central Nervous System Tumors Program, Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autonoma Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ctrv.2011.10.007DOI Listing
June 2012

Castration-resistant metastatic prostate cancer: current status and treatment possibilities.

Authors:
Joan Carles Daniel Castellano Miguel Ángel Climent Pablo Maroto Rafael Medina Antonio Alcaraz

Clin Transl Oncol 2012 Mar;14(3):169-76

Servicio de Oncología, Instituto de Oncología de la Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s12094-012-0780-8DOI Listing
March 2012

SEOM clinical guidelines for the treatment of invasive bladder cancer.

Authors:
Rafael Morales Albert Font Joan Carles Dolores Isla

Clin Transl Oncol 2011 Aug;13(8):552-9

Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s12094-011-0696-8DOI Listing
August 2011

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01.

Authors:
Joaquim Bellmunt Pablo Maroto-Rey José M Trigo Joan Carles Vicente Guillem José A López-Martín Antonio Antón-Torres Leyrer Urruticoechea

Clin Transl Oncol 2010 Jul;12(7):503-8

Medical Oncology Service, University Hospital del Mar, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s12094-010-0544-2DOI Listing
July 2010

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06).

Authors:
Joaquim Bellmunt José Manuel Trigo Emiliano Calvo Joan Carles José L Pérez-Gracia Jordi Rubió Juan Antonio Virizuela Rafael López Martín Lázaro Joan Albanell

Lancet Oncol 2010 Apr 15;11(4):350-7. Epub 2010 Feb 15.

Medical Oncology Service, University Hospital del Mar-IMIM, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(09)70383-3DOI Listing
April 2010

Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer.

Authors:
Joan Carles Miguel Nogue Josep M Sole Palmira Foro Montserrat Domenech Marta Suarez Enrique Gallardo Darío García Ferrán Ferrer Antoni Gelabert-Mas Javier Gayo Xavier Fabregat

Int J Radiat Oncol Biol Phys 2010 Mar 4;76(4):1085-91. Epub 2009 Jul 4.

Hospital del Mar, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2009.03.024DOI Listing
March 2010

Molecular basis for the treatment of renal cell carcinoma.

Authors:
Cristina Suárez Rafael Morales Eva Muñoz Jordi Rodón Claudia M Valverde Joan Carles

Clin Transl Oncol 2010 Jan;12(1):15-21

Department of Medical Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://link.springer.com/content/pdf/10.1007/s12094-010-0461
Web Search
http://link.springer.com/10.1007/s12094-010-0461-4
Publisher Site
http://dx.doi.org/10.1007/s12094-010-0461-4DOI Listing
January 2010

Impact of PSA implementation and combined radiation and hormonal therapy (RT+HT) on outcome of prostate cancer patients.

Authors:
Joaquim Bellmunt Francesc Macià Davide Malmusi José A Llorente Joan Carles Josep Lloreta Palmira Foro Antoni Gelabert Joan Albanell Xavier Castells

Eur J Cancer 2009 Nov 20;45(16):2804-9. Epub 2009 Jul 20.

Department of Medical Oncology, Hospital Universitari del Mar-IMIM Passeig Marítim 25-29, Barcelona E-08003, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ejca.2009.06.019DOI Listing
November 2009

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.

Authors:
Joaquim Bellmunt Christine Théodore Tomasz Demkov Boris Komyakov Lisa Sengelov Gedske Daugaard Armelle Caty Joan Carles Agnieszka Jagiello-Gruszfeld Oleg Karyakin François-Michel Delgado Patrick Hurteloup Eric Winquist Nassim Morsli Yacine Salhi Stéphane Culine Hans von der Maase

J Clin Oncol 2009 Sep 17;27(27):4454-61. Epub 2009 Aug 17.

Department of Medical Oncology, University Hospital Del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2008.20.5534DOI Listing
September 2009

Management and interpretation of novel toxicities of molecular targeted therapies: renal toxicities.

Authors:
Joan Carles Rafael Morales José Manuel Perez Cristina Suárez Jordi Rodón Claudia Valverde

Eur J Cancer 2009 Sep;45 Suppl 1:309-17

Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S0959-8049(09)70045-0DOI Listing
September 2009

Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents.

Authors:
Joaquim Bellmunt Clara Montagut Santiago Albiol Joan Carles Pablo Maroto Anna Orsola

BJU Int 2007 Feb 1;99(2):274-80. Epub 2006 Dec 1.

Oncology Department, Hospital del Mar, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1111/j.1464-410X.2006.06589.x
Publisher Site
http://dx.doi.org/10.1111/j.1464-410X.2006.06589.xDOI Listing
February 2007

Expression of cyclooxygenase-2 mRNA in peripheral blood of head and neck cancer patients and in healthy controls. A pilot study.

Authors:
Juan J Grau Mariano Monzó Miguel Caballero Joan Carles Ramón Palmero Rosa Artells Cesar Pico Pere Gascon

Acta Otolaryngol 2007 Jan;127(1):71-5

Oncology Department of Hospital Clinic, Faculty of Medicine, University of Medicine, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/00016480600672576DOI Listing
January 2007

Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer.

Authors:
Joan Carles Mariano Monzo Marta Amat Sonia Jansa Rosa Artells Alfons Navarro Palmira Foro Francesc Alameda Angel Gayete Bernat Gel Maribel Miguel Joan Albanell Xavier Fabregat

Int J Radiat Oncol Biol Phys 2006 Nov 18;66(4):1022-30. Epub 2006 Sep 18.

Department of Medical Oncology, Hospital del Mar, University Autonoma of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2006.06.029DOI Listing
November 2006

Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function.

Authors:
Joan Carles Cristina Suárez Carlos Mesía Miquel Nogué Albert Font Montserrat Doménech Marta Suárez Ignasi Tusquets M Gallén Joan Albanell Xavier Fabregat

Clin Transl Oncol 2006 Oct;8(10):755-7

Oncology Department. Hospital del Mar, URTEC, Universitat Autónoma de Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s12094-006-0123-8DOI Listing
October 2006

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

Authors:
Jorge Aparicio José R Germà Xavier García del Muro Pablo Maroto José A Arranz Alberto Sáenz Agustín Barnadas Joan Dorca Josep Gumà David Olmos Romá Bastús Joan Carles Daniel Almenar Miguel Sánchez Luis Paz-Ares Juan J Satrústegui Begoña Mellado Ana Balil Marta López-Brea Alfredo Sánchez

J Clin Oncol 2005 Dec 31;23(34):8717-23. Epub 2005 Oct 31.

Department of Medical Oncology, Hospital Universitario La Fe, Avda Campanar 21, E-46009 Valencia, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2005.01.9810DOI Listing
December 2005

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.

Authors:
Ricardo Hitt Antonio López-Pousa Javier Martínez-Trufero Vicente Escrig Joan Carles Alfredo Rizo Dolores Isla M Eugenia Vega Juan L Martí Francisco Lobo Pedro Pastor Vicente Valentí Joaquín Belón Miguel A Sánchez Carlos Chaib Cinta Pallarés Antonio Antón Andrés Cervantes Luis Paz-Ares Hernán Cortés-Funes

J Clin Oncol 2005 Dec 7;23(34):8636-45. Epub 2005 Nov 7.

Servicio de Oncología Médica, Hospital Universitario 12 de Octubre de Madrid, Carretera de Andalucía, km 5,400, 28041, Madrid, Spain.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2004.00.1990DOI Listing
December 2005

Her-2/neu expression in prostate cancer: a dynamic process?

Authors:
Joan Carles Josep Lloreta Marta Salido Albert Font Marta Suarez Veronica Baena Miquel Nogue Montserrat Domenech Xavier Fabregat

Clin Cancer Res 2004 Jul;10(14):4742-5

Oncology Unit, Hospital del Mar, Pathology Department, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://clincancerres.aacrjournals.org/content/10/14/4742.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-04-0115DOI Listing
July 2004

Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy.

Authors:
Miquel Nogué-Aliguer Joan Carles Antonio Arrivi Oscar Juan Lorenzo Alonso Albert Font Begoña Mellado Pilar Garrido Alberto Sáenz

Cancer 2003 May;97(9):2180-6

Oncology Unit, Corporació Sanitària Parc Taulí, Sabadell, Spain.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1002/cncr.10990
Publisher Site
http://dx.doi.org/10.1002/cncr.10990DOI Listing
May 2003

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.

Authors:
Joaquim Bellmunt Joan Albanell Luis Paz-Ares Miguel A Climent Jose L González-Larriba Joan Carles Juan J de la Cruz Vicente Guillem Eduardo Díaz-Rubio Hernan Cortés-Funes José Baselga

Cancer 2002 Aug;95(4):751-7

Medical Oncology Sevice, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1002/cncr.10762
Publisher Site
http://dx.doi.org/10.1002/cncr.10762DOI Listing
August 2002